Australia markets closed

Cisen Pharmaceutical Co., Ltd. (603367.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
17.86-0.84 (-4.49%)
At close: 3:00PM CST

Cisen Pharmaceutical Co., Ltd.

Tongji Sci-tech Industrial Park
High-tech Industrial Development Zone
Jining 272073
86 53 7298 0071

IndustryDrug Manufacturers—Specialty & Generic
Full-time employees2,983

Key executives

NameTitlePayExercisedYear born
Mr. Zhen Xin DuChairman & GMN/AN/A1967
Mr. Ting Zhen HanDeputy GM & DirectorN/AN/A1963
Mr. Liu Shan HeDeputy GM & DirectorN/AN/A1970
Mr. Hong Hui SunSec. of the BoardN/AN/A1975
Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.


Cisen Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells chemical drug preparations and health care products in China and internationally. The company's chemical drug preparations include liver disease drugs, antitumor and auxiliary drugs, nutrition preparations, contrast agents, antibiotics, digestive system agents, polypropylene ampoules, and external preparations, as well as sedation anesthesia, cardiovascular, cough and asthma, immunomodulator, infusion, and therapeutic infusion products. It also engages in the formulation, development, manufacturing, and marketing of generic pharmaceutical products. The company was formerly known as Shandong Lukang Cisen Pharmaceutical Co., Ltd. and changed its name to Cisen Pharmaceutical Co., Ltd. in 2011. Cisen Pharmaceutical Co., Ltd. is based in Jining, the People's Republic of China.

Corporate governance

Cisen Pharmaceutical Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.